Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Synthetic datasets for open software development in rare disease research. [PDF]
Al-Dhamari I, Abu Attieh H, Prasser F.
europepmc +1 more source
Software development process of Neotree - a data capture and decision support system to improve newborn healthcare in low-resource settings. [PDF]
Khan N+20 more
europepmc +1 more source
Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation
Pericytes alter their transcriptome depending on their proximity to the tumor core. In the tumor core, pericytes display a more active state with higher communication strength but with lower immune activation potential and a shift toward extracellular matrix production.
Carolina Buizza+5 more
wiley +1 more source
Glottis Recognition Software Development Using Artificial Intelligence. [PDF]
Masumori Y+4 more
europepmc +1 more source
Automated conversion of Millennium-120 VMAT plans to HDMLC geometry: Software development and treatment of first patients. [PDF]
Yang R+6 more
europepmc +1 more source
A Report on Recent Developments in Computing, Processor, and Software Research for High-Energy Physics: A Symposium Held in Guanajuato, Mexico May 8-11, 1984 [PDF]
Thomas H. Nash
openalex
A framework for the development and assurance of high integrity software
Dolores R Wallace, Laura M Ippolito
openalex +1 more source
Integration of usability issues within initial software development education. (It's all about the user dummy!) [PDF]
Xris Faulkner, Fintan Culwin
openalex +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha+10 more
wiley +1 more source